based on a series of clinical and laboratory studies of leukemia cell kinetics and responses to chemotherapy , we have developed an intensive timed-sequential regimen of daunorubicin and high-dose infusion 1-beta-d-arabinofuranosyl cytosine for the treatment of adult acute nonlymphocytic leukemia .
C0023418
cell kinetics
C0010711
arabinofuranosyl